Missouri

Missouri

State Facts

933

Deaths, or 63% of total overdose deaths involved opioids in 2024.¹

1.5 Million

Claims, or 4.3% of all Medicare Part D claims were for opioids in 2022 – an average of 64 per prescriber.²

47

Opioid Prescriptions were written for every 100 persons in Missouri in 2023.³

18,461

Beneficiaries on Medicare Part D had Opioid Use Disorder in 2022.⁴

Download FactSheet

Opioid Settlement Funds

$894,258,177.21
State Spending Recommendation

National approved use: providing support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain.

Member & Endorser Footprint

Voices is backed by a broad coalition of organizations across the state united by a shared goal: ensuring patients have access to safe, effective, 
and individualized pain management throughout the continuum of care.

2025 Introduced Relevant Legislation

HB 804 /SB 158

This bill prohibits health plans from favoring opioids over non-opioid medications for enrollees at elevated risk of opioid misuse, including through coverage denials, step therapy, or higher cost-sharing.

Introduced
01/08/2025
Plan Impact
Commercial
Learn More

Voices Letters

SB 158 Voices testimony

Learn More

SB 158 Sponsor Letter of Support

Learn More

1. Centers for Disease Control and Prevention (2025). Provisional Drug Overdose Death Counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

2. Centers for Disease Control and Prevention (2024). Medicare Part D Opioid Prescribing Mapping Tool. https://cms-oeda.maps.arcgis.com/apps/MapSeries/index.html?appid=5390718d875d4c049b1ac5976a9ff083

3. Center for Disease Control and Prevention (2024). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html

4. Office of the Inspector General (2023). The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern. https://oig.hhs.gov/documents/evaluation/2722/OEI-02-23-00250-Complete%20Report.pdf